There’s always something new and exciting going on at INTERPHEX. Check out our announcements for the very latest news.

Share This:

INTERPHEX and Pharmaceutical Technology Announce Keynote Series 2018 Program


NEW YORK, NY – February 20, 2018International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, and Pharmaceutical Technology and BioPharm International, two leading information sources for the global drug development and manufacturing community, today released the Keynote Series program for 2018. Attendees will have the opportunity to learn from industry and market leaders to address industry challenges and to cost effectively develop and manufacture product. INTERPHEX takes place April 17-19, 2018 at the Javits Center, New York, NY.

Oral Solid Dosage Manufacturing: Tuesday, April 17, 2018

Employing the Internet of Things and PAT for Solid Dosage Forms Manufacturing: 10:30 am-10:55 am 
Research underway at Innopharma Labs’ pilot facility in Dublin, Ireland, combines the concepts of Industrial Internet of Things (IIoT), Industry 4.0, machine-to-machine connectivity and the adoption of artificial intelligence. This approach uses process analytical technology tools to track and control process, laying the groundwork for real-time release and self-guided processing. 
Presenter: Ian Jones, CEO, Innopharma Labs

PCMM (Portable, Continuous, Miniature and Modular) OSD Manufacturing Facility Platform: 11:00 am-11:25 am
The PCMM Collaboration brought together the expertise of Pfizer, GSK, GEA, and G-CON to collectively develop the next generation OSD manufacturing platform to address the changing requirements of pharmaceutical manufacturing for flexible, agile, and rapidly deployable processing platforms. An overview of the PCMM program initiative will be presented, including a review of the original prototype facility design, which was installed at the Pfizer Groton, CT site in 2015, as well as an update on the PCMM 2nd Generation design that was initiated in 2016 when GSK joined the PCMM consortium. 
Presenter: Dennis Powers, Director of Sales Engineering, G-CON Manufacturing, Inc.

Continuous Manufacturing Roundtable: Best Practices for Implementation: 11:30 am-12:30 pm
The pharmaceutical industry has made progress in implementing continuous manufacturing for oral solid-dosage drugs. Commercial processes have been approved, and process understanding is growing. This expert panel will discuss the current capabilities, ongoing challenges, and best practices for configuring equipment, optimizing startup and changeover, handling cleaning and maintenance, and other equipment and system implementation issues. 
Moderator: Jennifer Markarian, Manufacturing Editor, Pharmaceutical Technology
Panelists: Dave DiProspero, Associate/Director Pharmaceutical Process Technology, CRB; Doug Hausner, PhD, Associate Director for the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University; Sharon Nowak, Global Business Development Manager, Food and Pharmaceuticals, Coperion K-Tron; José Luis Santos, PhD, Head of Operations, Drug Product Continuous Manufacturing, Hovione

Aseptic, Sterile, and Biologics Drug Manufacturing: Tuesday, April 17, 2018

Analytics and Instrumentation: Best Practices for Lyophilization: 1:30 pm-2:10 pm
Discussion is focused on best practices, lessons learned and advances in lyophilization technology.
Presenter:Alina Alexeenko, Professor, Purdue University and Founding Codirector, LyoHUB, the Advanced Lyophilization Technology Consortium

Continuous Manufacturing for Biopharm, Visions of an End-to-End Approach: 2:15pm-3:00pm
To date, the adoption of continuous manufacturing technology for bioprocessing remains slow, and where the technology is being used, it is limited to either downstream or upstream processing. This panel will discuss the major challenges, such as technology hurdles and regulatory or business roadblocks that biomanufacturers face in implementing continuous manufacturing. The panel will also explore the missing links in equipment or technology that are preventing the establishment of a fully integrated continuous manufacturing process for biologics.
Moderators: Rita Peters, Editorial Director, and Feliza Mirasol, Science Editor, Pharmaceutical Technology and BioPharm International
Panelists:Merrilee Whitney, Head of Next Generation Bioprocessing, MilliporeSigma; Parrish Galliher, Chief Technology Officer Upstream, GE Healthcare Life Sciences; Peter Levison, PhD, Senior Marketing Director, Downstream Processing, Pall Biotech; Surendra Balekai, Senior Global Product Manager-SUT, Thermo Fisher Scientific

Information Technology Trends and Best Practices: Wednesday, April 18

Regulatory Requirements for Data Integrity, Applying ALCOA+: 11:00 am-11: 30am
Presenter:Els Poff, PDA Data Integrity Task Force

Best Practices in Data Integrity and Process Security with Automated Systems: 11:30 am- 12:30 pm
A panel of industry experts, including representatives from Siemens, Emerson, Rockwell Automation, and Master Control, will discuss how to ensure data integrity with manufacturing automation systems, cybersecurity and best practices for auditing system security, and security concerns associated with the Industrial Internet of Things.
Moderator: Jennifer Markarian, Manufacturing Editor, Pharmaceutical Technology
Panelists: Nicolas Teissié, Siemens Industry Software Product Manager; Mark Cristiano, Manager, North America Business Development Team, Connected Services and Solutions, Rockwell Automation; to be confirmed from Emerson; to be confirmed from Master Control.

The Industrial Internet of Things, Blockchain and Smart Contracts: 1:30pm-2:10 pm
Within the past year, there have been considerable advances in the industrial internet of things (IIoT) and the use of sensors for logistics and distribution. Some companies are evaluating their use in blockchain-based smart contracts. These contracts would not only guarantee the authentication of a pharmaceutical’s pedigree, but would protect consumers, penalizing carriers for allowing cargo to be exposed to out-of-spec temperatures, pressures, and other conditions. In these presentations, experts will describe recent research into pharma’s use of these emerging IT-based technologies.
Moderator: Agnes Shanley, Senior Editor, Pharmaceutical Technology
Presenters:Robert Celeste, Director, Center for Supply Chain Studies; Jim Sabogal, Director of Healthcare, T-Systems, Inc. 

Serialization: Moving Beyond Compliance to Value: 2:15-3:00pm
Within the past few years, considerable progress has been made in serialization. What are the next steps?  How can companies begin to achieve ROI from their efforts so far, and how will use of standards guide broader traceability efforts in the future? Speakers from industry standards working groups and serialization integrators will share experiences and visions.
Moderator: Agnes Shanley, Senior Editor, Pharmaceutical Technology
Panelists: Charlie Gifford, Technical Director, Open-SCS Working Group; Evren Ozkaya, CEO, Supply Chain Wizard

See the full Technical Conference Program here. To register for your complimentary INTERPHEX Technical Conference and Exhibit Hall Pass, visit

About Pharmaceutical Technology and BioPharm International

Pharmaceutical Technology is the authoritative source of peer-reviewed research and expert analyses for scientists, engineers, and managers engaged in process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biopharmaceutical industries. BioPharm International integrates the science and business of biopharmaceutical research, development, and manufacturing through peer-reviewed papers and practical insight and research. Pharmaceutical Technology and BioPharm International are part of the UBM Life Sciences unit of UBM Americas, a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. The brands includes Pharmaceutical Technology, Pharmaceutical Technology Europe,, BioPharm International, and


For the past 39 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,500 global industry professionals and 620+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. FormulationX and foundation sponsored by Elsevier, Dow Chemical, Colorcon and Marcor Development will launch at the 2018 event to increase the presence on drug substance. INTERPHEX and FormulationX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and TwitterIPX Blog continues the learning beyond the show floor. For more information, visit

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.